Gregory M. Weinhoff

Insider Reports History

Location
Cheshire, United Kingdom
Signature
/s/ Gregory M. Weinhoff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory M. Weinhoff:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Business Officer Ordinary Shares 122,279 $1,902,636 $15.56 25 Jul 2025 Direct
Centessa Pharmaceuticals plc Chief Business Officer Share Option (right to buy) 55,000 25 Jul 2025 Direct

Insider Reports Filed by Gregory M. Weinhoff

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 25 Jul 2025 3 -$117,098 4 Chief Business Officer 25 Jul 2025, 18:24
CNTA Centessa Pharmaceuticals plc 25 Jun 2025 3 -$100,142 4 Chief Business Officer 25 Jun 2025, 19:44
CNTA Centessa Pharmaceuticals plc 27 May 2025 3 -$89,725 4 Chief Business Officer 27 May 2025, 18:31
CNTA Centessa Pharmaceuticals plc 25 Apr 2025 1 -$159,857 4 Chief Business Officer 25 Apr 2025, 20:20
CNTA Centessa Pharmaceuticals plc 25 Mar 2025 3 -$124,886 4 Chief Business Officer 26 Mar 2025, 16:16
CNTA Centessa Pharmaceuticals plc 25 Feb 2025 1 -$175,270 4 Chief Business Officer 26 Feb 2025, 16:24
CNTA Centessa Pharmaceuticals plc 01 Feb 2025 2 -$241,398 4 Chief Business Officer 04 Feb 2025, 16:55
CNTA Centessa Pharmaceuticals plc 27 Jan 2025 1 -$193,429 4 Chief Business Officer 28 Jan 2025, 16:32
CNTA Centessa Pharmaceuticals plc 31 Dec 2024 1 -$191,982 4 Chief Business Officer 31 Dec 2024, 16:32
CNTA Centessa Pharmaceuticals plc 26 Dec 2024 3 -$131,899 4 Chief Business Officer 26 Dec 2024, 18:10
CNTA Centessa Pharmaceuticals plc 25 Nov 2024 3 -$138,101 4 Chief Business Officer 27 Nov 2024, 16:20
CNTA Centessa Pharmaceuticals plc 25 Oct 2024 1 -$180,628 4 Chief Business Officer 25 Oct 2024, 19:19
CNTA Centessa Pharmaceuticals plc 30 Sep 2024 1 -$185,406 4 Chief Business Officer 02 Oct 2024, 16:32
CNTA Centessa Pharmaceuticals plc 25 Sep 2024 1 -$260,724 4 Chief Business Officer 27 Sep 2024, 16:15
CNTA Centessa Pharmaceuticals plc 10 Sep 2024 3 -$334,800 4 Chief Business Officer 12 Sep 2024, 20:01
CNTA Centessa Pharmaceuticals plc 09 Sep 2024 3 -$229,000 4 Chief Business Officer 09 Sep 2024, 17:06
CNTA Centessa Pharmaceuticals plc 22 Aug 2024 2 -$367,222 4 Chief Business Officer 23 Aug 2024, 17:12
CNTA Centessa Pharmaceuticals plc 30 Jun 2024 1 -$106,030 4 Chief Business Officer 02 Jul 2024, 16:33
CNTA Centessa Pharmaceuticals plc 31 Mar 2024 1 -$132,685 4 Chief Financial Officer 02 Apr 2024, 16:18
CNTA Centessa Pharmaceuticals plc 01 Feb 2024 3 -$94,136 4 Chief Financial Officer 02 Feb 2024, 17:08
CNTA Centessa Pharmaceuticals plc 31 Dec 2023 1 -$93,466 4 Chief Financial Officer 02 Jan 2024, 19:45
CNTA Centessa Pharmaceuticals plc 30 Sep 2023 1 -$75,971 4 Chief Financial Officer 03 Oct 2023, 16:56
CNTA Centessa Pharmaceuticals plc 30 Jun 2023 1 -$69,279 4 Chief Financial Officer 03 Jul 2023, 17:33
CNTA Centessa Pharmaceuticals plc 31 Mar 2023 1 -$32,339 4 Chief Financial Officer 04 Apr 2023, 17:04
CNTA Centessa Pharmaceuticals plc 01 Feb 2023 2 $0 4 Chief Financial Officer 03 Feb 2023, 16:09
CNTA Centessa Pharmaceuticals plc 31 Dec 2022 1 -$16,439 4 Chief Financial Officer 04 Jan 2023, 18:28
CNTA Centessa Pharmaceuticals plc 30 Sep 2022 1 -$47,948 4 Chief Financial Officer 13 Jan 2023, 16:41
CNTA Centessa Pharmaceuticals plc 30 Sep 2022 0 $0 4/A Chief Financial Officer 23 Nov 2022, 16:03
CNTA Centessa Pharmaceuticals plc 01 Jul 2022 1 $0 4 Chief Financial Officer 06 Jul 2022, 18:16
CNTA Centessa Pharmaceuticals plc 01 Feb 2022 1 $0 4 Chief Financial Officer 03 Feb 2022, 17:30
CNTA Centessa Pharmaceuticals plc 02 Jun 2021 4 +$200,000 4 Chief Financial Officer 04 Jun 2021, 17:00
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3/A Chief Financial Officer 04 Jun 2021, 16:45